Currently, Dr. Leonard serves as president and CEO of Intellia Therapeutics. Prior to Intellia, Dr. Leonard was the chief scientific officer and global vice president of research and development at AbbVie, according to an Oct. 25 3T news release.
Dr. Leonard has worked on HIV inhibitors Norvir and Kaletra as well as the top-selling arthritis pain reliever Humira.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.